AdaptHealth (AHCO) Insider Susan Weaver Buys 18,999 Shares

On June 24, 2026, Susan Weaver purchased 18,999 shares of AHCO. The transaction did not specify a price, but AHCO shares were trading at $10.18 on Saturday. This insider buying activity is a notable move, reflecting confidence in the company's prospects.

Other Institutional Activity in AHCO

In recent months, several institutional investors have adjusted their positions in AHCO. OEP Capital Advisors, L.P. increased its holdings by 2,494,518 shares, bringing its total to 16,312,698 shares valued at approximately $194.1 million. BlackRock, Inc. also grew its stake by 247,939 shares, ending with 15,939,953 shares worth about $189.7 million. Meanwhile, Reinhart Partners, LLC. added 1,981,198 shares to reach a total of 10,081,983 shares valued at around $120 million. FMR LLC increased its position by 423,256 shares, holding 8,054,691 shares valued at roughly $95.9 million.

AdaptHealth Corp. Stock Up 78.2%

Shares of AHCO traded at $10.18 on Saturday. The stock has seen a range over the past year, with a 52-week low and high yet to be specified. AHCO's market performance is closely watched by investors, especially given its recent insider and institutional activity.

Insider Buying and Selling at AdaptHealth Corp.

In addition to Susan Weaver's purchase, several other insider transactions occurred around the same time. On June 24, 2026, David Solomon Williams III also acquired 18,999 shares, while on June 1, 2026, Russell Schuster III, the Chief Commercial Officer, sold 11,275 shares at an average price of $10.06 under a planned transaction. Earlier, on May 27, 2026, Daniel Edward McFadden, the Chief Operating Officer, bought 20,134 shares.

Analysts Set New Price Targets

Analysts have maintained a positive outlook on AHCO. On May 11, 2026, RBC Capital maintained a 'buy' rating with a price target of $15. Canaccord Genuity and UBS also upheld their 'buy' ratings with targets of $16 and $14 respectively in early May. The consensus among analysts remains optimistic, with a strong 'buy' recommendation and targets ranging from $12 to $16.

Bottom Line

Susan Weaver's purchase of AHCO shares is a significant insider transaction that underscores potential confidence in the company. Institutional investors have also been active, with several funds increasing their holdings. Analysts continue to support AHCO with 'buy' ratings and favorable price targets. As always, it's important to remember that insider and institutional filings are backward-looking and may not reflect current positions.